Vice President Joe Biden Visits Memorial Sloan Kettering

 

Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson, MD, President and CEO of MSK. Select from our library of high-resolution photos and b-roll footage available for download below.

 

Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson, MD, President and CEO of MSK. MSK’s Carol Brown, MD, Ross Levine, MD, and Robert Sidlow, MD, were also active participants in the discussion. For more information about the event or to request an interview with a MSK roundtable participant, please e-mail mediastaff@mskcc.org.
Thursday, May 26, 2016
 
The lack of participation in clinical research may be the Achilles heel facing today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of MSK, only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. For more information or to schedule an interview, please contact mediastaff@mskcc.org.
Monday, May 23, 2016
 
Memorial Sloan Kettering experts are available to comment on new research presented at the American Association for Cancer Research 2016 Annual Meeting including immunotherapy and CAR T cells, exercise oncology, precision medicine and more. For more information and to set up interviews or access photos, email Nicole H. McNamara at mcnamarn@mskcc.org.
Friday, April 15, 2016
 
See all trending topics
 

Press Releases

 
The lack of participation in clinical research may be the Achilles’ heel of today’s cancer community. According to a new survey of more than 1,500 consumers and nearly 600 physicians conducted on behalf of Memorial Sloan Kettering Cancer Center (MSK), only 35 percent of Americans indicated that they were “likely” to enroll in a clinical trial. Other studies have shown that only 4 percent of cancer patients enroll in clinical trials nationally each year.
Monday, May 23, 2016
 
Memorial Sloan Kettering Cancer Center (MSK) will further enhance its ability to offer top cancer care to even more patients with the establishment of a freestanding, state-of-the-art outpatient treatment center in Bergen County, New Jersey. Residents from communities across northern New Jersey and southern New York State will have easier access to MSK’s unique expertise when MSK Bergen becomes fully operational in winter 2017.
Tuesday, May 10, 2016
 
The Society of Memorial Sloan Kettering Cancer Center (MSK) has announced that Richard J. O’Reilly, MD, has been named the inaugural recipient of The Society of Memorial Sloan Kettering Prize. This new award recognizes an individual who has made outstanding contributions to the field of pediatric oncology.
Monday, May 2, 2016
 
See all press releases
 

On Our Blog

 
IN THE NEWS
Find out what Vice President Joe Biden had to say when he visited MSK for a roundtable “cancer moonshot” discussion.
Friday, May 27, 2016
 
FINDING
Most people are aware of how important clinical trials are and how they can lead to lifesaving breakthroughs, but they’re also unlikely to participate in them.
Monday, May 23, 2016
 
IN THE CLINIC
The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.
Thursday, May 19, 2016
 
See all blog posts
 

Media Coverage

 
Chief of the Immigrant Health and Cancer Disparities Service, Francesca Gany, is profiled in the New York Daily News
Saturday, April 23, 2016
 
Surgeon Behfar Ehdaie was interviewed about prostate cancer risks in Reuters
Saturday, April 23, 2016
 
Gynecologic oncologist Ginger Gardner discusses new research about ovarian cancer risks with NBC News.com.
Thursday, April 21, 2016
 
See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Senior Communications Associate, Department of Surgery
 
Courtney Nowak
Senior Media Relations Associate
 
Caitlin Hool
Senior Media Associate
 
Nicole H. McNamara
Senior Media Relations Associate
 
Rebecca Williams
Media Associate
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.

Subscribe to the News@MSKCC newsletter

Our email newsletter for journalists offers the latest advances in cancer research and treatment, including story ideas, institutional milestones and plans, and newsworthy staff accomplishments.

Sign up

Unsubscribe »